Zobrazeno 1 - 9
of 9
pro vyhledávání: '"G Z, Chkadua"'
Autor:
I. N. Mikhaylova, M. N. Stakheyeva, I. Zh. Shubina, G. Z. Chkadua, A. A. Borunova, R. A. Zukov, I. V. Bogdashin, E. L. Choynzonov, N. V. Cherdyntseva
Publikováno v:
Сибирский онкологический журнал, Vol 22, Iss 2, Pp 43-55 (2023)
The aim of the study was to identify differences in the immune system parameters between metastatic melanoma patients who responded and did not respond to dendritic cell vaccination.Material and Methods. The study group included 20 patients with stag
Externí odkaz:
https://doaj.org/article/4e5a950f43e148efbffe01740e782666
Autor:
Yu. A. Khochenkova, G. Z. Chkadua, I. V. Samoylenko, T. F. Malivanova, I. N. Mikhailova, L. V. Demidov, E. V. Stepanova
Publikováno v:
Медицинская иммунология, Vol 15, Iss 6, Pp 563-570 (2014)
Abstract. Increased VEGF levels in cancer patients may be associated with decreased number of dendritic cells (DCs) and lower DC function. We investigated whether VEGF gene polymorphisms -2578C>A (rs699947) and +936C>T (rs3025039) are associated with
Externí odkaz:
https://doaj.org/article/eeb026a56774434f9e4bf5856688d7d3
Autor:
Natalia N. Petenko, Anastasia S. Vihrova, Alvina A. Molodyk, Irina N. Mikhaylova, Irina Zh. Shubina, Natalia V. Balatskaya, Mikhail V. Kiselevsky, O. S. Burova, Vadim I. Pospelov, Kermen A. Parsunkova, G. Z. Chkadua, Dmitrii K. Chebanov, Valeria V. Nazarova, Robert Sh. Beabelashvili, Lev V. Demidov, L. F. Morozova, Evgeny A. Cheremushkin
Publikováno v:
Oncotarget
// Irina N. Mikhaylova 1 , Irina Zh. Shubina 1 , George Z. Chkadua 1 , Natalia N. Petenko 1 , Lidia F. Morozova 1 , Olga S. Burova 1 , Robert Sh. Beabelashvili 2 , Kermen A. Parsunkova 3 , Natalia V. Balatskaya 4 , Dmitrii K. Chebanov 5 , Vadim I. Po
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8327ccea11d28b201bec04b5efb635fb
https://doi.org/10.18632/oncotarget.25274
https://doi.org/10.18632/oncotarget.25274
Autor:
D. A. Nosov, A. A. Borunova, G. Z. Chkadua, V. B. Matveyev, E. S. Yakovleva, M. Yu. Fedyanin, Z. G. Kadagidze, T. N. Zabotina, S. A. Tyulyandin
Publikováno v:
Onkourologiâ, Vol 6, Iss 2, Pp 22-31 (2014)
Objective: to study the efficiency and tolerance of autologous vaccine therapy based on dendritic cells (DC) in patients with renal cell carcinoma (RCC) and to examine changes in immunological parameters and their association with the efficiency of t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::68f4f9fb4a0d170a5a1b461f9346aff3
https://oncourology.abvpress.ru/oncur/article/view/43
https://oncourology.abvpress.ru/oncur/article/view/43
Publikováno v:
Urologiia (Moscow, Russia : 1999). (5)
Dendritic cells (DC) are most potent antigen-presenting cells controlling immune response by means of interaction with lymphocytes. Antitumor vaccines based on DC are produced by means of the patient's DC culturing and loading with tumor antigens in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::3f9e35928c4773db4df2628a96918edd
https://pubmed.ncbi.nlm.nih.gov/19069498
https://pubmed.ncbi.nlm.nih.gov/19069498
Autor:
G. Z. Chkadua, Lev V. Demidov, Galina Kharkevich, Valery V. Nazarova, Tatiana Zabotina, Olga V. Korotkova, Anastasia S Vikhrova, Igor Samoylenko, Irina N. Mikhaylova
Publikováno v:
Journal of Clinical Oncology. 31:e20042-e20042
e20042 Background: The purpose of this sub study was to identify peripheral blood biomarkers associated with the therapeutic effect of immunotherapy with dendritic cell vaccine in patients with metastatic melanoma (MM). Methods: Patients (pts) with l
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d4f9b740c9abf0c680fbeebb56ecdf81
https://doi.org/10.1200/jco.2013.31.15_suppl.e20042
https://doi.org/10.1200/jco.2013.31.15_suppl.e20042
Autor:
Irina N. Mikhaylova, Olga V. Korotkova, Lev V. Demidov, Igor Samoylenko, Tatiana Zabotina, G. Z. Chkadua, K. Baryshnikov
Publikováno v:
Annals of Oncology. 23:ix371
Introduction We performed a vaccine trial in metastatic melanoma patients with a stable disease course. Aim Primary end point was 6-month progression-free survival; secondary end points included overall survival, progression free survival, immunologi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5d360ec6326e0a72e59729de1fd4b8b8
https://doi.org/10.1016/s0923-7534(20)33693-0
https://doi.org/10.1016/s0923-7534(20)33693-0
Autor:
Anatoly Y. Baryshnikov, Lev V. Demidov, Irina N. Mikhaylova, G. Z. Chkadua, Natalia N. Petenko
Publikováno v:
Journal of Clinical Oncology. 30:2524-2524
2524 Background: Earlier DC vaccine therapy demonstrated clinical benefit in some patients (pts) with advanced melanoma although the effect was seen only in pts with minimal tumor burden (ASCO2007 abstract No: 3077). As there is no effective treatmen
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::183122da39b0fc1dd41b18a8162bb16a
https://doi.org/10.1200/jco.2012.30.15_suppl.2524
https://doi.org/10.1200/jco.2012.30.15_suppl.2524
Autor:
Irina N. Mikhaylova, Kadagidze Zg, Natalia N. Petenko, E. A. Cheremushkin, Anatoly Y. Baryshnikov, L. Y. Vishnyakova, G. Z. Chkadua, S. A. Hatirev, Lev V. Demidov, E. V. Ogorodnokova
Publikováno v:
Journal of Clinical Oncology. 25:3077-3077
3077 Background: Vaccination with dendritic cells (DC) expressing tumor antigens is considered to be a possible strategy to induce anti-tumour immune responses in treatment of melanoma. Methods: 42 stage III and IV melanoma patients were enrolled int
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::300658095257c6507801d1a2b4caf860
https://doi.org/10.1200/jco.2007.25.18_suppl.3077
https://doi.org/10.1200/jco.2007.25.18_suppl.3077